A wide range of opioid misuse motives have been documented in the literature, including to relieve physical pain, feel good/get high, relax, manage feelings/emotions, sleep, and moderate the effects of other substances. Despite a rise in opioid misuse among African Americans over the last 2 decades, their motivations for misuse remain unclear. Much of the research on opioid misuse motivations either rely on samples with little racial diversity or do not stratify their findings by race. As a result, less is known about the specific reasons why African Americans engage in opioid misuse. The objective of this study, therefore, was to identify and explain the most common motives for misusing opioids among African Americans. Qualitative interview data are also presented to explain/contextualize the most prevalent motivations.
Methods:
This study used data from the Florida Minority Health Survey, a mixed-methods project that included online surveys (n = 303) and qualitative in-depth interviews (n = 30) of African Americans. Data collection was conducted from August 2021 to February 2022 throughout Southwest Florida.
Results:
Analyses revealed that while some (33.9%) misused opioids for purposes of recreation/sensation seeking (eg, feel good/get high), the majority (66.1%) were attempting to self-treat perceived medical symptoms (eg, physical pain, anxiety/trauma, withdrawals, insomnia).
Conclusions:
This study contributes to a better understanding of why some African Americans engage in opioid misuse and findings highlight the need for interventions to be trauma informed and address unmanaged physical pain among African Americans. Given that most studies on motivations are quantitative in nature, the study contributes to the literature by capturing the voices of African Americans who use drugs.
Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality; 2021. https://wwwsamhsagov/data
2.
Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings. Substance Abuse and Mental Health Services Administration; 2003.
3.
UbaROAnkoma-DarkoKParkSK.International comparison of mitigation strategies for addressing opioid misuse: a systematic review. J Am Pharm Assoc. 2020;60(1):195-204.
4.
LangabeerJRStottsALBobrowBJ, et al. Prevalence and charges of opioid-related visits to US emergency departments. Drug Alcohol Depend. 2021;221:108568.
5.
OwensPLWeissAJBarrettML.Hospital Burden of Opioid-Related Inpatient Stays: Metropolitan and Rural Hospitals. Agency for Healthcare Research and Quality; 2016.
6.
Mackesy-AmitiMEDonenbergGROuelletLJ.Prescription opioid misuse and mental health among young injection drug users. Am J Drug Alcohol Abuse. 2015;41(1):100-106.
7.
RiggKKDeCampW.Explaining prescription opioid misuse among veterans: a theory-based analysis using structural equation modeling. Mil Behav Health. 2014;2(2):210-216.
8.
SurrattHKurtzSPCiceroTJ.Alternate routes of administration and risk for HIV among prescription opioid abusers. J Addict Dis. 2011;30(4):334-341.
9.
ButtramMEKurtzSPSurrattHLLevi-MinziMA.Health and social problems associated with prescription opioid misuse among a diverse sample of substance-using MSM. Subst Use Misuse. 2014;49(3):277-284.
10.
RiggKKRiggMS.Opioid-induced hearing loss and neonatal abstinence syndrome: clinical considerations for audiologists and recommendations for future research. Am J Audiol. 2020;29(4):701-709.
11.
SzalavitzMRiggKK.The curious (dis) connection between the opioid epidemic and crime. Subst Use Misuse. 2017;52(14):1927-1931.
12.
ChavezMNRiggKK.Nutritional implications of opioid use disorder: a guide for drug treatment providers. Psychol Addict Behav. 2020;34(6):699.
13.
KariisaMDavisNLKumarS, et al. Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics—25 states and the District of Columbia, 2019–2020. Morb Mort Wkly Rep. 2022;71(29):940.
14.
FriedmanJAkreS.COVID-19 and the drug overdose crisis: uncovering the deadliest months in the United States, January-July 2020. Am J Public Health. 2021;111(7):1284-1291.
15.
HendenEMelbergHORøgebergOJ.Addiction: choice or compulsion?Front Psychiatry. 2013;4:77.
16.
PomazalRJBrownJD.Understanding drug use motivation: a new look at a current problem. J Health Soc Behav. 1977;18:212-222.
17.
MaslowAH.A theory of human motivation. Psychol Rev. 1943;50:370-396.
18.
SchepisTSWastilaLAmmermanBMcCabeVVMcCabeSE.Prescription opioid misuse motives in US older adults. Pain Med. 2020;21(10):2237-2243.
19.
McCabeSEWestBTBoydCJ.Motives for medical misuse of prescription opioids among adolescents. J Pain. 2013;14(10):1208-1216.
20.
SchepisTSDe NadaiAFordJMcCabeSE.Prescription opioid misuse motive latent classes: outcomes from a nationally representative US sample. Epidemiol Psychiatr Sci. 2020;29:e97.
21.
RiggKKIbañezGE.Motivations for non-medical prescription drug use: a mixed methods analysis. J Subst Abuse Treat. 2010;39(3):236-247.
22.
BoydCJMcCabeSECranfordJAYoungA.Adolescents’ motivations to abuse prescription medications. Pediatrics. 2006;118(6):2472-2480.
23.
YoungAMcCabeSECranfordJARoss-DurowPBoydCJ.Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use. J Addict Dis. 2012;31(4):332-341.
24.
RiggKKSharpA.Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): implications for risk reduction. Addict Behav. 2018;79:159-165.
25.
RiggKKMcLeanKMonnatSMSternerIIIGEVerderyAM.Opioid misuse initiation: implications for intervention. J Addict Dis. 2018;37(3-4):111-122.
26.
HanBComptonWMBlancoCJonesCM.Correlates of prescription opioid use, misuse, use disorders, and motivations for misuse among US adults. J Clin Psychiatry. 2018;79(5):15323.
27.
BoydCJMcCabeSE.Coming to terms with the nonmedical use of prescription medications. Subst Abuse Treat Prev Policy. 2008;3(1):1-3.
28.
McCabeSEBoydCJTeterCJ.Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend. 2009;102(1-3):63-70.
29.
McCabeSEBoydCJCranfordJATeterCJ.Motives for nonmedical use of prescription opioids among high school seniors in the United States: self-treatment and beyond. Arch Pediatr Adolesc Med. 2009;163(8):739-744.
30.
DrazdowskiTKSchulteMWolitzky-TaylorKBSchaperHChapmanJE.Motivations for prescription drug misuse related to mental health problems in adults. Subst Use Misuse. 2022;57(2):316-327.
31.
RiggKKNicholsonHL.Prescription opioid misuse among African American adults: a rural-urban comparison of prevalence and risk. Drug Alcohol Depend. 2019;197:191-196.
32.
FordJARiggKK.Racial/ethnic differences in factors that place adolescents at risk for prescription opioid misuse. Prev Sci. 2015;16:633-641.
33.
SethPSchollLRuddRABaconS.Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. Am J Transplant. 2018;18(6):1556-1568.
34.
FriedmanJRHansenH.Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry. 2022;79(4):379-381.
35.
McCabeSECranfordJA.Motivational subtypes of nonmedical use of prescription medications: results from a national study. J Adolesc Health. 2012;51(5):445-452.
36.
TeterCJMcCabeSECranfordJABoydCJGuthrieSK.Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health. 2005;53(6):253-262.
37.
CuryJDSharmaVFaliseAMTerryELLopez-QuinteroC.Racial-ethnic differences in reasons for misuse of prescription medications among US adults. J Addict Med. 2022;16(4):470.
38.
NicholsonHLJr.Socioeconomic status, fundamental cause theory, and prescription opioid use behaviors: a theoretical examination. Sociol Spectr. 2020;40(1):1-32.
39.
Substance Abuse and Mental Health Services Administration. The Opioid Crisis and the Black/African American Population: An Urgent Issue. Substance Abuse and Mental Health Services Administration; 2020.
40.
SantoroTNSantoroJD.Racial bias in the US opioid epidemic: a review of the history of systemic bias and implications for care. Cureus. 2018;10(12):e3733.
BrodyGHKoganSMChenYF.Perceived discrimination and longitudinal increases in adolescent substance use: gender differences and mediational pathways. Am J Public Health. 2012;102(5):1006-1011.
43.
SampsonRJ.Great American City: Chicago and The Enduring Neighborhood Effect. University of Chicago Press; 2012.
44.
WallaceJMMuroffJR.Preventing substance abuse among African American children and youth: race differences in risk factor exposure and vulnerability. J Prim Prev. 2002;22:235-261.
45.
ChoiYHarachiTWGillmoreMRCatalanoRF.Are multiracial adolescents at greater risk? Comparisons of rates, patterns, and correlates of substance use and violence between monoracial and multiracial adolescents. Am J Orthopsychiatry. 2006;76(1):86-97.
46.
CreswellJW.A Concise Introduction to Mixed Methods Research. SAGE Publications; 2014.
47.
US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. National survey on drug use and health: summary of methodological studies, 1971–2014. 2015. Accessed December 2, 2022. https://www.ncbi.nlm.nih.gov/books/NBK519735/
48.
ChromyJFederMGfroererJ, et al. Reliability of Key Measures in the National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2009.
49.
HilalAHAlabriSS.Using Nvivo for data analysis in qualitative research. Int J Incl Educ. 2013;2(2):181-186.
50.
BergsonHBlumerHCharmazKHutchinsonS. Qualitative interviewing and grounded theory analysis. Inside Interview. 2003:310-330.
51.
PalamarJJLeAClelandCM.Nonmedical opioid use among electronic dance music party attendees in New York City. Drug Alcohol Depend. 2018;186:226-232.
52.
McCabeSECranfordJABoydCJTeterCJ.Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav. 2007;32(3):562-575.
53.
KenneDRHamiltonKBirminghamLOglesbyWHFischbeinRLDelahantyDL.Perceptions of harm and reasons for misuse of prescription opioid drugs and reasons for not seeking treatment for physical or emotional pain among a sample of college students. Subst Use Misuse. 2017;52(1):92-99.
54.
LordSBrevardJBudmanS.Connecting to young adults: an online social network survey of beliefs and attitudes associated with prescription opioid misuse among college students. Subst Use Misuse. 2011;46(1):66-76.
55.
KecojevicACorlissHLLankenauSE.Motivations for prescription drug misuse among young men who have sex with men (YMSM) in Philadelphia. Int J Drug Policy. 2015;26(8):764-771.
56.
AbdelWahabMAAbouelMagdSFGrellaCEEnabaDAAbdel MaqsoudR.An examination of motives for tramadol and heroin use in an Egyptian sample. J Addict Dis. 2018;37(3-4):123-134.
57.
PeprahPAgyemang-DuahWAppiah-BrempongEAkwasiAGMorganAK.“With tramadol, I ride like a Jaguar”: a qualitative study of motivations for non-medical purpose tramadol use among commercial vehicle operators in Kumasi, Ghana. Subst Abuse Treat Prev Policy. 2020;15(1):1-15.
58.
ZuckermanM. Sensation seeking and substance use and abuse: smoking, drinking, and drugs. In: ZuckermanM, ed. Sensation Seeking and Risky Behavior. American Psychological Association; 2007:107-143.
59.
LangAShinMLeeS.Sensation seeking, motivation, and substance use: a dual system approach. Media Psychol. 2005;7(1):1-29.
60.
MerloLJSinghakantSCummingsSMCottlerLB.Reasons for misuse of prescription medication among physicians undergoing monitoring by a physician health program. J Addict Med. 2013;7(5):349.
61.
Levi-MinziMASurrattHLKurtzSPButtramME.Under treatment of pain: a prescription for opioid misuse among the elderly?Pain Med. 2013;14(11):1719-1729.
62.
DangerfieldIIDTHeidariOCooperJAllenSLucasGM.Motivations for opioid and stimulant use among drug using black sexual minority men: a life course perspective. Drug Alcohol Depend. 2020;215:108224.
63.
GroenewaldCBPatelKVRabbittsJAPalermoTM.Correlates and motivations of prescription opioid use among adolescents 12-17 years of age in the United States. Pain. 2020;161(4):742.
64.
SinghalATienYYHsiaRY.Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. PloS One. 2016;11(8):e0159224.
65.
PletcherMJKerteszSGKohnMAGonzalesR.Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299(1):70-78.
66.
SinghAK.Alcohol interaction with cocaine, methamphetamine, opioids, nicotine, cannabis, and γ-hydroxybutyric acid. Biomedicines. 2019;7(1):16.
67.
BehzadiMJoukarSBeikA.Opioids and cardiac arrhythmia: a literature review. Med Princ Pract. 2018;27(5):401-414.
68.
HoffmanRS.Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside. Br J Clin Pharmacol. 2010;69(5):448-457.
69.
SturzaMLCampbellR.An exploratory study of rape survivors’ prescription drug use as a means of coping with sexual assault. Psychol Women Q. 2005;29(4):353-363.
70.
ShermanSSPlittSul HassanSChengYTariq ZafarS.Drug use, street survival, and risk behaviors among street children in Lahore, Pakistan. J Urban Health. 2005;82:iv113-iv124.
71.
KhantzianEJMackJESchatzbergAF.Heroin use as an attempt to cope: clinical observations. Am J Psychiatry. 1974;131(2):160-164.
72.
VanderplasschenWRappRCDe MaeyerJVan Den NoortgateW.A meta-analysis of the efficacy of case management for substance use disorders: a recovery perspective. Front Psychiatry. 2019;10:186.
73.
MorandiSSilvaBGolayPBonsackC.Intensive case management for addiction to promote engagement with care of people with severe mental and substance use disorders: an observational study. Subst Abuse Treat Prev Policy. 2017;12(1):26.
74.
RhodesWMGrossM.Case Management Reduces Drug Use and Criminality Among Drug-Involved Arrestees: An Experimental Study of an HIV Prevention Intervention. US Department of Justice, Office of Justice Programs, National Institute of Justice; 1997.
75.
LeeATChinPNambiarAHill HaskinsN.Addressing intergenerational trauma in Black families: Trauma-informed socioculturally attuned family therapy. J Marital Fam Ther. 2023;49(2):447-462.
76.
RobertsALGilmanSEBreslauJBreslauNKoenenKC.Race/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United States. Psychol Med. 2011;41(1):71-83.
